Australia has made great progress towards hepatitis C elimination, with an estimated 60% of people living with hepatitis C having already been treated, but more work is needed if Australia is to eliminate hepatitis C as a ...
Dec 4, 2023
0
0
A breakthrough in the understanding of the relationship between a naturally occurring enzyme and the liver cancer drug sorafenib could improve the effectiveness of the drug, which currently prolongs the life of liver cancer ...
Dec 4, 2023
0
53
New research delves into a traditionally overlooked category of chronic hepatitis B (CHB) patients. While those who are HBeAg-negative with normal ALT levels have been considered low-risk and often excluded from immediate ...
Dec 1, 2023
0
0
A recent study reveals significant insights into the challenges that can occur for hepatitis C virus (HCV) micro-elimination efforts in people with HIV (PWH). Due to the opioid epidemic, the prevalence of co-infection with ...
Nov 30, 2023
0
0
Two-week direct-acting antiviral (DAA) prophylaxis prevents hepatitis C virus (HCV) infection in individuals without HCV viremia who received kidney transplant (KT) from donors with HCV viremia (HCV D+/R−), according to ...
Nov 28, 2023
0
1
Direct-acting antiviral agents (DAAs) remain underutilized in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), according to a study presented at The Liver Meeting, the annual meeting of the American ...
Nov 21, 2023
0
0
Hepatitis B virus (HBV) is a significant public health problem, with over 296 million people chronically infected worldwide. Despite the availability of a safe and effective vaccine for over 40 years, HBV remains a leading ...
Nov 13, 2023
0
0
Telemedicine is widely perceived as an important tool for potentially improving health care access for the underserved. However, few randomized controlled trials have been conducted to determine its effectiveness in treating ...
Nov 10, 2023
1
0
Driven by the ongoing opioid epidemic and the sharing of needles, hepatitis C cases have been rising in the United States over the last decade, with the highest infection rates among young adults, including women of childbearing ...
Nov 8, 2023
0
0
Recommendations have been developed for hepatitis C virus (HCV) testing among perinatally exposed infants. The recommendations and report are published in the Nov. 3 issue of Morbidity and Mortality Weekly Report.
Nov 3, 2023
0
0
